The expression of beta-adrenoceptors (BAR) was investigated in abdominal and gluteal fat cells of 32 nonobese men and women using radioligand binding and RNA excess solution hybridization.
Introduction
Catecholamines are the major lipolysis-promoting hormones in adult human fat cells (1) . This effect is mediated by betaadrenoceptors (BAR).' In human fat cells, unlike in adipocytes from most other species, catecholamines also have antilipolytic properties that are mediated by alpha2-adrenoceptors. It is well established that there are marked regional variations in catecholamine-induced lipolysis; the hormones are much more lipolytic in abdominal than in gluteal/femoral human adipocytes (2) (3) (4) (5) . It has been suggested that site variations in lipolysis may be of importance for the difference in body fat distribution in men and in women and for the development of different types of regional obesity (6) (7) (8) . [5,7-3H] benzimidazole-2-1 hydrochloride; '25ICYP, ' 25-I-cyanopindolol; TNA, total nucleic acids.
The mechanisms underlying regional variations in lipolysis have been partly elucidated (9) . It appears that an increase in the number of BAR (with normal affinity and normal coupling to lipolysis) is the major factor underlying an enhanced lipolytic effect of catecholamines in abdominal as compared with gluteal human fat cells. This may involve both BAR subtypes. The existence of BAR 1 and BAR 2 has been demonstrated in isolated human fat cells (10) , and both receptor subtypes are coupled to lipolysis (1 1).
The factors responsible for variations in BAR content between fat cells from different adipose deposits are not known. Differences in gene expression, mRNA/protein processing, or protein degradation may be involved. In this study, we have investigated whether variations in BAR number between fat cells from different regions also involve differences in expression of the genes encoding for BAR 1 and BAR 2. Thus, steady-state mRNA levels for these two genes, as well as mRNA stability, were determined in abdominal and gluteal fat cells. mRNA was measured using solution hybridization techniques. The findings with mRNA have been related to cell surface BAR content in the adipocytes, which was determined by radioligand binding techniques.
Methods
Subjects. 32 healthy volunteers (17 men and 15 women) participated in the study. They were all drug free. None of the women had taken oral contraceptives during the preceding 6-mo period. Their ages were 23-55 yr (mean±SE:33±2 yr). All were ofnormal weight and the body mass index was 24.0±0.3 kg/m2. All subjects gave their informed consent and the study was approved by the Ethics Committee ofHuddinge Hospital. After the subjects had fasted overnight, one subcutaneous specimen (2-3 g) was excised from the infraumbilical region (abdominal site) and one from the upper lateral quadrant of the gluteal region under local anesthesia, as described previously (9) . A part of the tissue was immediately frozen in liquid nitrogen and stored at -70°C. Fat cells were isolated from the remaining part as described previously (12) . Some ofthese cells were frozen and stored as above. The remaining cells were used for receptor binding, as described below.
Receptor binding assays. Incubations were carried out under steady-state conditions, as described in detail elsewhere (12) . Briefly, -20,000 fat cells were incubated in triplicate at 37°C in 1 ml of Krebs-Ringer phosphate buffer (pH 7.4) containing 5 g/liter bovine serum albumin, 1 g/liter glucose, and 0.1 g/liter ascorbic acid plus radioligands.
In most of the experiments one low and one high concentration of radioligand was used. It was possible to perform complete saturation experiments in only six ofthe subjects because the amounts ofadipose tissue available were limited. The hydrophobic antagonist '251-cyanopindolol ('25ICYP) was used in the saturation experiments and the hydrophilic antagonist (±) -4(3-butylamino-2-hydroxypropoxy) - [5,7- 3H]benzimidazole-2-1 hydrochloride (3HCGP) was used in the other experiments. We have repeatedly shown (9, 13) that these radioligands bind to a single class ofhomogeneous, noninteracting binding sites that give straight lines on a Scatchard analysis and Hill coefficients near 1. Under such conditions, the use of two radioligand concentrations to determine antagonist-binding capacity seems reliable, because both binding points will be distributed along the same regression line.
Adipocyte measurements. The fat cell volume and the number of fat cells incubated were determined as described previously (10) .
Preparation of nucleotides. For solution hybridization analysis, total nucleic acids (TNA) were prepared by digestion of homogenized adipose tissue or fat cells with proteinase K in an SDS-containing buffer (1% SDS; 10 mmol/liter of Tris, pH 7.5; 5 mmol/liter of EDTA; protein kinase K, 100 mg/liter) and subsequent extraction with phenol-chloroform by the addition of isomylic ethanol (vol 24:1) (14) . The concentration of nucleic acids was measured spectrophotometrically.
Northern blot analysis required -20 g of subcutaneous adipose tissue, which was obtained during elective cholecystectomy on two male nonobese subjects (ages 47 and 50, respectively), but were otherwise healthy. The tissue was extracted as described above. Total RNA was prepared by the acid quanidum thiocyanate method combined with the CsC12 centrifugation procedure (15) . The amount ofRNA was estimated from the optical density at 260 nm.
Preparation ofhybridization probes. Complementary oligonucleotide probes (50 bases) were synthesized and hybridized to each other in a procedure described by Melton et al. (16) . In addition, the hybrid contained recognition sequences for the restriction enzymes Pst 1 and Hind III. The constructions were cloned into the Pst 1/Hind III sites in pGEM-3 (Promega Biotec., Madison, WI). The sequences of these insertions were confirmed by DNA sequencing using the dideoxy chain-termination method (17) . The plasmid was employed for in vitro synthesis of cRNA using SP6 RNA polymerase, and for the opposite mRNA strand using T7RNA polymerase. For (20) .
Northern blot hybridization. This assay was performed essentially as described by Maniatis et al. (7) . RNA samples (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) Mug) were denaturated for 10 min at 65°C in dimethylsulphoxide (50%), formaldehyde (2.2 mol/liter), sodium phosphate (10 mmol/liter, pH 7.5), EDTA (0.5 mmol/liter), and then electrophoresed through an agarose gel (1.2%) containing formaldehyde (2.2 mol/liter) in sodium phosphate (10 mmol/liter, pH 7.5) for 500 V-h in a running buffer containing morpholinopropane sulphonic acid (0.04 mmol/liter, pH 7.4), sodium acetate (10 mmol/liter), and EDTA (I mmol/liter). The integrity of RNA samples was verified after gel electrophoresis by ethidium bromide staining. After two 30-min equilibrations in 20X SSC (3 mol/ liter ofNaCI, 0.3 mol/liter of sodium citrate), the RNA was transferred by the Southern technique to hybond-N filters (Amersham Corp., Buckinghamshire, UK). Nylon membranes to which RNA had been transferred, were then prehybridized for 2 h at 55°C in 50% formamide, 5X SSC (1.0 mol/liter of NaCl, 0.1 mol/liter ofsodium citrate), 5X Denhardt's solution (0.02% of Ficoll, 0.02% of polyvinyl pyrrolidine, and 0.02% of bovine serum albumin), 5 mmol/liter ofphosphate buffer (pH 6.5), 5 mmol/liter of SDS, and 200 Ag/ml of salmon testis DNA. Hybridization was carried out for 40 h at 55°C in an identical solution containing 4-6 X 102 cpm/ml of 32P-labeled cRNA probe. After hybridization, the filter was washed serially with 0.1 X SSC and 0.1% of SDS at 68°C to eliminate non-specific binding ofthe probes to the filter and ribosomal RNA. Autoradiographs were obtained by exposure to Kodak XAR-5 film with an intensifying screen for 48 h at 70°C. Molecular weight standards corresponding to RNA species of 28S and 18S were prepared from MCF7 cells. RNA for BAR, and BAR2 were electrophoresed on the same gel and blotted over to the same filter. The filter was cut into different lanes for subsequent hybridization to either the BAR, probe or the BAR2 probe.
Solution hybridization. This assay was carried out mainly as described previously (21) . Briefly, [35S]UTP cRNA was hybridized (20,000 cpm/sample) at 701C to TNA samples. RNA hybrids were allowed to form in a buffer consisting of 0.6 mol/liter of NaCl, 30 mmol/liter of Tris HCL (pH 7.5), 5 mmol/liter of EDTA, 0.1 % SDS, 10 mmol/liter of dithiothreitol, and 25% of formamide. After an overnight incubation, samples were treated with RNase for 45 min at 370C by adding I ml ofa solution containing 40Mgg RNase A and 2 ,g RNase TI (both from Boehringer-Mannheim, Mannheim, FRG). RNase-resistant radioactivity was precipitated by the addition of 0.1 ml of trichloro acetic acid (6 mol/liter) and collected on glass fiber filters (Whatman Inc., Clifton, NJ). Sample TNA hybridization was compared with a known amount of an in vitro synthesized mRNA strand (complementary to the radioactive probe). A standard curve (0.5-30 X 10-8 mol mRNA/incubation) was included in each assay. Each TNA sample was analyzed in duplicate and the amount of BAR, mRNA or BAR2 mRNA was related to the amount of DNA in the TNA sample. Results are expressed as molecules/cell, assuming a content of6.4 pg of DNA/adipocyte.
Statistical methods. The values presented are means±SE. Regression analysis, the F-distribution t test for comparing two regression lines and the paired and unpaired t tests were used for statistical comparison of the results.
Results
Adipose cellularity. Adipocytes from the gluteal region were larger than those from the abdominal region, the adipocyte volume being 572±27 pl vs. 453±27 pl (P < 0.001). Moreover, the fat cells from males were somewhat smaller than those from women in both regions. These data confirm the results from several laboratories, including a recent study done by us (9) .
Radioligand binding. The binding of labeled beta-adrenoceptor ligand was significantly increased in abdominal adipocytes as compared with gluteal adipocytes (Fig. 1) . This was true when two concentrations of the radioligand 3HCGP were used (in all subjects) as well as in the saturation experiments with '25ICYP binding (six subjects).
If the results using the two different concentrations of each radioligand are representative of complete saturation experiments, they indicate that the number of beta-adrenoceptor binding site is almost twice as high in abdominal adipocytes as in gluteal adipocytes. Moreover, the Scatchard analysis of complete saturation experiments with '25ICYP displayed straight and parallel lines for binding to both abdominal and gluteal cells. This shows that there was no difference between the two sites in adrenoceptor affinity for the radioligand. The Scatchard analysis also demonstrated that the maximum binding capacity of '25ICYP was almost twice as high in abdominal as in gluteal adipocytes (P < 0.01). Thus, there was an almost twofold difference between abdominal and gluteal cells in the number of beta-adrenoceptors. The sex of the subjects had no significant effect on beta-adrenoceptor binding (data not shown). The binding data were expressed per cell number. The regional differences in binding were even more marked when expressed per cell surface area. The findings with BAR binding confirm previous results from our laboratory concerning gluteal and abdominal human adipocytes (9) .
Measurements of mRNA. In this study we used cRNA probes derived from synthetic oligonucleotides (50 bases) in order to quantify specific BAR 1 and BAR 2 mRNA species. The sequences of the probes were obtained from published sequences and were confirmed by DNA sequencing. The hybridization conditions in the assay were determined from an analysis of the melting point of RNA-RNA hybrids (data not Figure 1 In methodological studies, mRNA for beta-actin was measured in adipose segments of six men and six women. In women, the values (molecules/cell) were 75±8 and 73±8 in the abdominal and gluteal regions, respectively. The corresponding values in men were 69±9 and 76±12. Thus, betaactin mRNA showed no sex or regional variation. In order to determine whether there existed any regional differences in mRNA stability, adipose tissue segments were incubated in vitro with the RNA polymerase inhibitor actinomycin D (Fig. 6 ). mRNA for BAR 1 and BAR 2 declined as a function of time (semilogarithmic relationship). However, there was no difference in the rate of decline between the two mRNA species or between regions. The apparent half-life of both mRNA species was -6 h.
Discussion
In this study, the possible functional importance of BAR gene expression has been investigated for the first time in man. The expression of receptor protein may be regulated at both the transcriptional and the posttranscriptional levels. The latter includes effects on mRNA stability, translation efficiency, protein turnover, or a modification ofthe protein that alters its biological activity.
Our study shows that the BAR receptor number is higher in abdominal than in gluteal adipocytes of men and women. This is in consonance with our earlier study (9) . Since we also measured mRNA levels for the genes that encode for BAR, it is possible to understand the molecular mechanisms that may be responsible for the variations in BAR expression between different types of adipocytes for the first time. (22, 23) . Therefore, it is not possible to measure these mRNA levels in small amounts of human adipose tissue with the standard quantitative Northern blot analysis because this method has low sensitivity. In this study, we measured mRNA levels using a very sensitive solubilization hybridization assay. Previously, BAR 2 mRNA has been determined in hamster DDT1 MF-2-cells using this technique (22, 23) . The steady-state levels of BAR 2 mRNA appear to be in the same order of magnitude in these hamster cells as in human fat cells.
Although BAR, and BAR2 are encoded by different genes, previous studies have indicated similarities among BAR subtypes in immunological and photoaffinity labeling properties as well as in the SDS-polyacrylamide gel electrophoresis migration pattern (Mr = 65,000-67,000) for both receptor subtypes (24) . These data suggest that the molecular basis for the subtype specificity of BAR may be due to posttranslational modification. However, studies by Babouth et al. (25) and Strader et al. (26) , using a cDNA probe for the hamster BAR2, indicated that posttranslational modification of the receptor by a cell in which it is expressed does not dictate subtype specificity. We also found that the size of the mRNA species encoding for the BAR, (2.5 kb) was larger than that encoding for the BAR2 (2.2 kb). This confirms previous results in other tissues (18, 19) and indicates an important structural difference between the two mRNA species in human fat cells. Thus, it seems likely that in human fat cells the subtype character of the BAR is the result ofthe expression ofseparate but homogeneous genes. Recently, a BAR3 gene has been isolated in man (27) . Whether this gene is also expressed in human fat cells remains to be established.
Our results indicate that the specific regulation of BAR subtype expression in human adipose tissue involves transcriptional rather than posttranscriptional mechanisms. The results of recent studies indicate that hormones which are important for fat cells, such as catecholamines and glucocorticoids, can alter transcription of BAR genes resulting in corresponding changes of the steady-state BAR mRNA levels (28, 29) . Thus, the presently observed regional difference in mRNA levels for BAR1 and BAR2 may be due to variations in the action of hormones or other regulatory agents on BAR gene transcription in adipocytes from different fat depots. However, posttranscriptional regulation of BAR protein expression in fat cells must be considered as well. It has recently been demonstrated that catecholamines have posttranscriptional effects on BAR mRNA levels. These hormones seem to promote destabilization of mRNA (30) .
In fat cells of either sex or region, the basal BAR1 mRNA levels were -50% higher than the BAR2 mRNA levels. This was not due to any differences in RNA stability, as judged by the experiments with actinomycin D. The latter may indicate that there is a variation in gene transcription activity between the BAR subtypes in human fat cells. The functional importance ofthe observed difference in mRNA expression of BAR1 and BAR2 is not known at present since, for reasons discussed previously, we were not able to determine the number of each receptor subtype in this study. However, previous studies from our laboratory suggest that the proportion of BAR1 relative to BAR2 binding sites in intact human fat cells is 4 to 1 (10) . We have also found that the lipolytic order ofpotency for catecholamines in isolated human fat cells indicates a preponderance of BAR, (31) . Thus, previous functional studies from our own laboratory regarding the two BAR subtypes are in agreement with the present mRNA data.
In the Northern blot analyses (Fig. 2) , the mRNA signals for BAR1 and BAR2 were ofsimilar strengths, which may seem at odds with the solution hybridization data. It should, however, be stressed that the Northern blot experiments were not designed to be quantitative. Instead they were used to test the specificity of the probes and to investigate the size of each mRNA species. Neither the amount of RNA that was blotted nor the hybridization conditions were standardized in the rigorous way that is necessary for quantitative Northern blot analysis.
In summary, abdominal adipocytes have more BAR binding sites than do fat cells from the gluteal area in men and women. This can be explained by an increased expression of the genes that encode for BAR 1 and BAR 2 in the former cells. This difference in gene expression constitutes a molecular mechanism for regional variations in adipocyte lipolysis activity.
